Compass Therapeutics to Participate in Upcoming Investor Events
November 13, 2024 08:30 ET
|
Compass Therapeutics
BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
AC Immune to Present at the Jefferies 2024 London Healthcare Conference
November 13, 2024 07:00 ET
|
AC Immune SA
AC Immune to Present at the Jefferies 2024 London Healthcare Conference Lausanne, Switzerland, November 13, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...
Immunocore to present at upcoming investor conferences
November 08, 2024 07:00 ET
|
Immunocore Holdings plc
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology...
Pineapple Energy to Host Virtual Fireside Chat
November 04, 2024 08:45 ET
|
Pineapple Energy
Pineapple Energy CEO Scott Maskin will sit down with Julien Dumoulin-Smith for a Fireside Chat on the solar industry on November 14 at 10:00 AM ET.
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
October 31, 2024 08:00 ET
|
Barinthus Biotherapeutics
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
Coave Therapeutics to Present Novel Data Highlighting the Potential of its ALIGATER™ Platform to Enhance the Targeted Delivery of Genetic Medicines at Upcoming Conferences
September 24, 2024 06:00 ET
|
Coave Therapeutics
Paris, France, September 24, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company pioneering therapies for eye and neurodegenerative diseases, will present the first data on its...
Early Warning News Release: Disposition of Series 3 Cumulative Redeemable Preferred Shares of Bombardier Inc.
July 22, 2024 08:40 ET
|
Jefferies LLC
EARLY WARNING NEWS RELEASE DISPOSITION OF SERIES 3 CUMULATIVE REDEEMABLE PREFERRED SHARES OF
BOMBARDIER INC.
Celcuity To Participate in Jefferies Global Healthcare Conference
June 03, 2024 16:01 ET
|
Celcuity Inc.
MINNEAPOLIS, June 03, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its...
Hillman Successfully Reprices Senior Term Loan Lowering Interest Expense
March 26, 2024 16:15 ET
|
The Hillman Group
CINCINNATI, March 26, 2024 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, successfully...
Icosavax to Participate in the Jefferies London Healthcare Conference
November 08, 2023 08:00 ET
|
Icosavax, Inc.
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...